Medline (MDLN) Insider buying
3 open-market purchases of MDLN by Medline's executives and directors since December 2025, worth $150M in total, from SEC Form 4 filings.
Summary
The most recent: Jessi L Corcoran, Principal Accounting Officer bought $170,750 on June 5, 2026.
The biggest buyer over the period is Andrew J Mills: 1 purchase, $75M.
By year
| Year | Purchases | Value |
|---|---|---|
| 2026 | 1 | $170,750 |
| 2025 | 2 | $150M |
Biggest buyers
| Insider | Buys | Value |
|---|---|---|
| Andrew J Mills | 1 | $75M |
| Charles N Mills | 1 | $75M |
| Jessi L Corcoran Principal Accounting Officer | 1 | $170,750 |
Every purchase
Newest first. From SEC Form 4 filings. Insider buying across the market.
Questions about Medline
Are Medline insiders buying the stock?
3 open-market purchases of MDLN by Medline's executives and directors since December 2025, worth $150M in total, from SEC Form 4 filings. The most recent: Jessi L Corcoran, Principal Accounting Officer bought $170,750 on June 5, 2026.
What counts as insider buying here?
Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.
From Medline's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.